Drug – bio-affecting and body treating compositions – Topical sun or radiation screening – or tanning preparations
Reexamination Certificate
2007-07-31
2007-07-31
Nutter, Nathan M. (Department: 1711)
Drug, bio-affecting and body treating compositions
Topical sun or radiation screening, or tanning preparations
C514S183000, C514S210030, C514S211070, C514S222200, C514S277000, C514S430000, C514S449000, C514S475000, C514S506000, C514S579000, C514S663000, C514S665000, C514S667000, C514S668000, C514S670000, C514S706000, C514S716000, C514S723000, C514S762000, C514S766000
Reexamination Certificate
active
11251217
ABSTRACT:
Disclosed are methods and compositions for regulating the melanin content of mammalian melanocytes; regulating pigmentation in mammalian skin, hair, wool or fur; treating or preventing various skin and proliferative disorders; by administration of various compounds, including alcohols, diols and/or triols and their analogues.
REFERENCES:
patent: 3956361 (1976-05-01), Stephen
patent: 4102995 (1978-07-01), Hebborn
patent: 4104203 (1978-08-01), Hall et al.
patent: 4390532 (1983-06-01), Stüttgen et al.
patent: 4528126 (1985-07-01), Bruns et al.
patent: 4647585 (1987-03-01), Loots et al.
patent: 5041485 (1991-08-01), Eichenauer et al.
patent: 5068453 (1991-11-01), Kuwahara et al.
patent: 5130136 (1992-07-01), Shono et al.
patent: 5190978 (1993-03-01), Nakamura et al.
patent: 5232688 (1993-08-01), Ziegler et al.
patent: 5302378 (1994-04-01), Crotty et al.
patent: 5352440 (1994-10-01), Gilchrest et al.
patent: 5414019 (1995-05-01), Gould et al.
patent: 5525635 (1996-06-01), Moberg
patent: 5532001 (1996-07-01), Gilchrest et al.
patent: 5554359 (1996-09-01), Fuller
patent: 5574195 (1996-11-01), Chastain et al.
patent: 5587402 (1996-12-01), Gould et al.
patent: 5591423 (1997-01-01), Fuller
patent: 5602184 (1997-02-01), Myers et al.
patent: 5626839 (1997-05-01), Scales-Medeiros
patent: 5698184 (1997-12-01), Pickart
patent: 5700450 (1997-12-01), Gilchrest et al.
patent: 5730987 (1998-03-01), Omar
patent: 5990177 (1999-11-01), Brown
patent: 6214888 (2001-04-01), Ren et al.
patent: 6231837 (2001-05-01), Stroud et al.
patent: 6267948 (2001-07-01), Ren et al.
patent: 6294585 (2001-09-01), Brown
patent: 6623724 (2003-09-01), Brown et al.
patent: 6955804 (2005-10-01), Brown et al.
patent: 0 643 113 (1995-03-01), None
patent: 1 200 862 (1970-08-01), None
patent: WO 87 04617 (1987-07-01), None
patent: WO 89 00853 (1989-02-01), None
patent: WO 96 09810 (1996-04-01), None
patent: WO 96/26711 (1996-09-01), None
patent: WO 97 03170 (1997-01-01), None
patent: WO 97 30692 (1997-08-01), None
patent: WO 98/11882 (1998-03-01), None
patent: WO 98 55085 (1998-12-01), None
patent: WO 99 08654 (1999-02-01), None
Abdel-Malek et al., “Mitogenic, Melanogenic, and cAMP Responses of Cultured Neonatal Human Melanocytes to Commonly Used Mitogens,”J. Cell. Physiol.,1992, 150:416-425.
Adnot et al., “Pulmonary hypertension: NO therapy?,”Thorax,1996, 51:762-764.
Allan et al., “Topically Applied Diacylglycerols Increase Pigmentation in Guinea Pig Skin,”J. Invest. Dermatol.,1995, 105:687-692.
Andersson and Stief, “Neurotransmission and the contraction and relaxation of penile erectile tissues,” 1997,World J. Urol.15:14-20.
Andersson, K.-E., “Neurotransmitters and neuroreceptors in the lower urinary tract,”Curr. Opin. Obstet. Gynecol.,1996, 8:361-365.
Anwer et al., “Essential Role of Sodium and Chloride for Theophylline-Induced Choleresis in the Isolated Perfused Rat Liver,”Proceedings of the Society for Experimental Biology and Medicine,176:70-76, 1984.
Barnhart et al., “Characteristics Common to Choleretic Increments of Bile Induced by Theophylline, Glucagon and SQ-20009 in the dog,”Proceedings of the Society for Experimental Biology and Medicine,150:591-596, 1975.
Baron, A., “Insulin and the Vasculature—Old Actors, New Roles,”J. Investig. Med.,1996, 44:406-412.
Barrera et al., “Effect of Epomediol on the ATPase and Adenylate Cyclase Activities in Plasmamembranes Isolated from Rat Liver,”Pharmacological Research Communications,16:1133-1140, 1984.
Barthelman et al., “Inhibitory Effects of Perillyl Alcohol on UVB-induced Murine Skin Cancer and AP-1 Transactivation,”Cancer Research,1998, 58:711-716.
Baudouin et al., “Constitutive Nitric Oxide Synthase Is Present in Normal Human Keratinocytes,”J. Invest. Dermatol.,1996, 106:428-431.
Bradford, M. “A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye Binding,”Anal. Biochem.,1967, 72:248-254.
Brann et al., “Gaseous Transmitters and Neuroendocrine Regulation,”Neuroendocrinology,1997, 65:385-395.
Brown et al., “Aliphatic and Alicyclic Diols Induce Melanogenesis in Cultured Cells and Guinea Pig Skin, Journal of Investigative Dermatology,” 1998, 110:428-437.
Buchbauer et al., “Norbornanaverbindungen in der pharmazeutischen Forschung,”Pharmazie,1991, 46(Teil 1):88-97, and 46(Teil 2):116-170.
Buchbauer et al., “Syntheses in the isocamphane series,”Chemical Abstracts,vol. 95, No. 115756e, 1981.
Carsberg et al., “Ultraviolet radiation-induced melanogensis in human melanocytes,”J. Cell. Sci.,1994, 107:2591-2597.
Carter et al., “Nitric oxide production is intensely and persistently increased in tissue by thermal injury,”Biochem. J.,1994, 304(Pt 1):201-04.
Chijiwa et al., “Inhibition of Forskolin-induced Neurite Outgrowth and Protein Phosphorylation by a Newly Synthesized Selective Inhibitor of Cyclic AMP-dependent Protein Kinase,N-[2-(p-Bromocinnamyl-amino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D Pheochromocytoma Cells,”J. Biol. Chem.,1990, 265:5267-5272.
Cho, Won Kyoo, “Role of the Neuropeptide, Bombesin, in Bile Secretion,”Yale Journal of Biology and Medicine,70:409-416, 1997.
Cieszka et al., “Growth and pigmentation in genetically related Cloudman S91 melanoma cell lines treated with 3-isobutyl-1-methyl-xanthine and β-melanocyte-stimulating hormone,”Exp. Dermatol.,1995, 4:192-198.
Cooke and Dzau, “Nitric Oxide Synthase: Role in the Genesis of Vascular Disease,”Annu. Ref. Med.,48:489-509, 1997.
Crowell et al., “Chemoprevention of mammary carcinogenesis by hydroxylated derivatives ofd-limonene,”Carcinogenesis,1992, 13:1261-1264.
Crowell et al., “Structure-activity relationships among monoterpene inhibitors of protein isoprenylation and cell proliferation,”Biochemical Pharmacology,1994, 47:1405-1415.
Dawson et al., “Nitric Oxide Actions in Neurochemistery,”Neurochem. Int.,1996, 29:97-110.
Eller et al., “DNA damage enhances melanogenesis,”Proc. Natl. Acad. Sci.,1996, 93:1087-1092.
Francis et al., “cAMP stimulates the secretory and proliferative capacity of the rat intrahepatic biliary epithelium through changes in the PKA/Src/MEK/ERK1/2 pathway,”Journal of Hepatology,41:528-537, 2004.
Friedmann et al., “Ultraviolet Radiation Directly Induces Pigment Production by Cultured Human Melanocytes,”J. Cell. Physiol.,1987,133:88-94.
Fuller et al., “Hormonal Regulation of Melanogenesis in Mouse Melanoma and in Human Melanocytes,”Ann. NY Acad. Sci.,1993, 690:302-319.
Fuller et al., “Regulation of Tyrosinase in Mouse Melanoma Cells and in Human Melanocytes by PKC and PKA Pathways,”Pigment Cell Res.,26thInternational Pigment Cell Conference Abstacts, 1996, S5:65.
Garvey et al., “Potent and Selective Inhibition of Human Nitric Oxide Synthases,”J. Biol. Chem.,1994, 269:26669-26676.
Gates et al., “Comparison of skin color with melanin content,”J. Invest. Dermatol.,1953, 21:339-348.
Gilchrest et al., “Mechanisms of Ultraviolet Light-Induced Pigmentation,”Photochem. Photobiol.,1996, 63:1-10.
Gorfine, S., “Treatment of Benign Anal Disease with Topical Nitroglycerin,”Dis. Colon Rectum,1995, 38:453-456.
Haag et al., “Mammary carcinoma regression induced by perillyl alcohol, a hydroxilated analog of limonene,”Cancer Chemotherapy and Pharmacology,1994, 34:477-483.
Hasenfratz “Experience in the treatment of acne vulgaris with the preparation acne-medice,”Asthetische Medizin,15:206-208, 1966.
He et al., “Isoprenoids Suppress the Growth of Murine B16 Melanomas In Vitro and In Vivo,”J. Nutr.,1997, 127:668-674.
Hidaka et al., “Isoquinolinesulfonamides, Novel and Potent Inhibitors of Cyclic Nucleotide Dep
Brown David A.
Khorlin Alexander A.
Lesiak Krystyna
Ren Wu Yun
Applied Genetics Incorporated Dermatics
Klee Maurice M.
Nutter Nathan M.
LandOfFree
Dermatological compositions and methods does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dermatological compositions and methods, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dermatological compositions and methods will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3750164